Why One Vaccine Cannot Protect Against All E. Coli Infections

Trending 1 day ago

The bacterium E. coli is nan astir communal origin of urinary tract infections and bloodstream infections. But successful nan hunt for vaccines, researchers person discovered that nan germs are much resilient than they had thought.

Most group person E. coli arsenic portion of their gut microbiota. As agelong arsenic it stays successful nan gut, it mostly doesn't origin trouble. But if it ends up successful different parts of nan body, it tin lead to infection, specified arsenic urinary tract infections and bloodstream infections. This tin beryllium peculiarly superior for older group and those pinch cancer.

Becoming much and much antibiotic-resistant

Many group are fixed antibiotics to cure an infection. However, nan predominant usage of antibiotics has led to a number of variants of E. coli becoming multi-resistant. This intends that respective types of antibiotics nary longer activity against them, which poses a awesome threat to nationalist health.

A vaccine could trim antibiotic resistance

Researchers truthful dream that it will beryllium imaginable to create vaccines against nan bacterium.

"It could some trim nan usage of antibiotics and beryllium of awesome use to group pinch weakened immune systems, specified arsenic older group and crab patients," explains Rebecca Gladstone. She is simply a interrogator astatine nan Department of Biostatistics astatine nan Institute of Basic Medical Sciences astatine nan University of Oslo.

One vaccine will not activity against each infections

In a caller study published successful Nature Microbiology, she and her collaborators collected information from 18,000 diligent samples successful a number of countries astir nan world. They studied nan specifications of nan bacterium's familial worldly done alleged genome sequencing.

E. coli, for illustration germs successful wide are reliable survivors and truthful person a protective capsule astir them. Such capsules are made of different types of sweetener layers that nan germs hide down to evade our immune strategy and to defy different biology pressures.

And present nan researchers encountered a caller situation successful nan study. They recovered that location was much variety successful this protective strategy than they had assumed.

We discovered 90 different variants of specified protective capsules connected E. coli bacteria. Only a 3rd of these were antecedently known."

Rebecca Gladstone, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo

Researchers will target vaccines astatine nan astir communal variants causing infections

There are, however, successful countries specified arsenic Norway, a fistful of variants that relationship for half of nan urinary tract infections and bloodstream infections. These successful move origin galore of nan infections wherever nan bacterium is resistant, meaning that it withstands astatine slightest 1 type of antibiotic.

"The 2 astir communal capsules, K1 and K5, mimic quality sugar-coated proteins domiciled connected nan surfaces of our cells. So these cannot beryllium utilized straight successful vaccines. For germs that person these 2 types of capsules, we truthful person to find different features of nan bacterium for nan vaccine to target," says Gladstone.

"In Norway, we tin still execute a batch if we create vaccines that woody pinch conscionable a fewer types of protective capsules. In low-income countries, nan image is much complicated," Gladstone says.

"There they person moreover greater variety successful these protective capsules. In immoderate case, this intends we cannot create conscionable 1 vaccine that will activity against each E. coli bacteria. We will astir apt person to attraction our efforts connected nan types that astir often origin infections, and those that lead to nan astir terrible infections."

Researchers must find caller ways to termination nan bacteria

In nan future, we whitethorn consequence having nary curen for infections if germs go resistant to each life-saving antibiotics.

"In summation to vaccines, we besides request to activity connected processing accelerated diagnostics. It will besides beryllium important to find methods of sidesplitting nan germs without resorting to ample amounts of broad-spectrum antibiotics," says Gladstone.

The study was carried retired successful collaboration pinch researchers from nan Wellcome Sanger Institute and is partially funded by nan Trond Mohn Research Foundation.

Source:

Journal reference:

Gladstone, R. A., et al. (2026). Identification of transporter-dependent capsular loci associated pinch nan invasive imaginable of Escherichia coli. Nature Microbiology. DOI: 10.1038/s41564-026-02283-w. https://www.nature.com/articles/s41564-026-02283-w

More